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A B S T R A C T
Aim: We present the application of a modern telemetric method that records and 
monitors Intracranial Pressure (ICP) over long periods in patients with possible in-
tracranial hypertension.
meThodS: A telemetric device (Raumedic®, Neurovent® P-tel) was surgically im-
planted in six patients, three with inconclusive diagnosis of benign intracranial hy-
pertension, two with possible diagnosis of aqueduct stenosis and one with Normal 
Pressure Hydrocephalus. All patients underwent a 3-day ICP recording within the 
nursing unit. Two more recordings were obtained over a period of 2-6 months at an 
outpatient basis. 
ReSulTS: All patients had an uncomplicated post-operative course. Analysis of the 
data excluded the diagnosis of idiopathic intracranial hypertension in two patients, 
whereas in four patients the data confirmed elevated ICP values. Three of patients 
underwent shunt implantation, while one patient refused further neurosurgical treat-
ment. 
ConCluSionS: The telemetric device could be safely implanted in selected patients. 
It could provide long-term ICP recordings, which are necessary to confirm diagnosis 
and guide the appropriate treatment.
i n T R o d u C T i o n
It is well known that he intracranial cavity contains 3 individual volumes: a) the 
brain tissue (approximately 1400 ml), b) the cerebrospinal fluid - CSF (100-150 ml) 
and c) the blood in the cerebral vessels (100-150 ml). The mean pressure exerted 
by the above masses into the cranial cavity consists the intracranial pressure (ICP). 
ICP follows the periodic variations of the vascular volume from the pulse wave and 
the respiratory cycle and can be recorded in a waveform. The final ICP histogram is 
generated by grouping measurements of the individual pressures. The ICP histogram 
results from the merging of the normal distributions of the pressures’ curves. These 
distributions follow the Gauze’s curve model. These pressures follow the pressures 
of the heartbeat, since in each heartbeat the brain pulsates. Consequently, the P1 
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(peak 1) reflects blood brain flow, P2 (peak 2) reflects brain 
compliance, and P3 (peak 3) reflects the impulse wave of the 
heartbeat. Correspondingly S1 (spread 1), S2 (spread 2) and S3 
(spread 3) are the distribution range of each Gaussian curve. 
The periodicity of the ICP waveform is similar to that of the 
heartbeat1,2 (Figure 1).
The difference in pressure between Mean Arterial Pres-
sure (MAP) and Cerebral Venous Pressure (CVP) is the 
Cerebral Perfusion Pressure (CPP). Because cerebral venous 
pressure is close to ICP it implies that CPP = mAP - iCP. 
The Cerebral Blood Volume (CBV) depends on cerebral 
blood tone and cerebrovascular resistances (CVRs), which 
are altered to achieve the necessary Cerebral Blood Flow 
(CBF). The CBF appears as follows: CBF = CPP / CVR. 
There are self-regulating mechanisms that tend to maintain 
CBF constant regardless of CPP from 50-150mmHg. Most 
conditions that induce intracranial hypertension are accom-
panied by a disruption of self-regulating mechanisms and CBF 
increases according to CPP. The ICP in normal conditions 
ranges between 10-13mmHg when measured in the lumbar 
region (lateral squat).1,3,4 Elevated ICP increases cerebral 
vascular resistance, resulting in a decrease in cerebral blood 
flow. During prolonged intracranial hypertension a number 
of metabolic events take place such as an increase in tissue 
concentrations of lactic and pyruvic acid, a significant degree 
of lactic acidosis, a decrease in ATP, phosphocreatine tyrosine 
and bicarbonate due to a disturbance of oxidative metabolism. 
This leads to damage to cerebrovascular function and tissue 
hyperemia, particularly following the reversal of intracranial 
hypertension. In pathological conditions elevated ICP occurs 
with the lundberg type B and type C waves, which represent 
enhancements in the physiological fluctuations of ICP, result-
ing from the systolic heart rate and the respiratory cycle. In 
situations with ICP >60mmHg, the Type A (plateau waves) 
have a height of 50-100mmHg and a duration of 5-20 minutes, 
indicating immediate treatment and poor prognosis for brain 
damage (Figure 2). Non-specific clinical manifestations of 
elevated ICP include headache, nausea, vomiting, diplopia, 
papillary edema, and reduced level of consciousness.3,5,6 
Invasive neuromonitoring with intracranial intraparenchy-
mal or intraventricular catheters has long been used to moni-
tor ICP waves and detect their increased values. However, its 
application is usually limited to a few days in order to avoid 
infectious complications. 
Over the years technologies enabling long term ICP moni-
toring have been demanded. Pathologies with elevated ICP, 
such as aqueduct stenosis causing obstructive hydrocephalus, 
benign intracranial hypertension (BIH), ventriculo-peritoneal 
(V-P) or lumbar-peritoneal (L-P) shunt malfunction and Nor-
mal Pressure Hydrocephalus (NPH)3,7-13 have been the most 
intended indications for long-term recording and analysis of 
ICP waveforms. Further on the derived information could be 
extremely useful for diagnosis and decisions making for further 
therapeutic action.
Since 1965, many technical proposals had been recom-
mended for “wireless” ICP monitoring. However, no device 
has been commercially used in routine clinical practice until 
quite recently. In 2009 Raumedic® Company introduced a new 
telemetric device called Neurovent® P-tel. Following experimen-
tal animal trials confirmed measuring accuracy with long-term 
stability. Since 2012, many reports for telemetric ICP monitoring 
in patients have been published14-20. Interestingly, in 2016 Ants 
et all presented their reports with P-tel on a total of 247 patients 
with suspected or known ICP disorders over a 6 year period16.
FiguRe 1. Normal ICP waveform.
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In this study we present our preliminary results in six pa-
tients with suspected intracranial hypertension, who submitted 
to long-term ICP monitoring with the Neurovent® P-tel Rau-
medic device. Technical aspects, indications, clinical efficacy, 
complications and data analysis possibilities are reviewed. 
m e T h o d S  –  P A T i e n T S
Between September 2016 and January 2018, six patients 
aged between 21 and 63 years, with mean age 36.6 years, 
involved in this study. Four were females and two males and 
all were categorized according to their possible pathology in 
three groups:
 - Aqueduct Stenosis (Occlusive Hydrocephalus): two pa-
tients (Figure 3)
 - Benign Intracranial Hypertension (BIH): three patients 
(Figure 4)
 - Normal Pressure Hydrocephalus (NPH): one patient 
All had symptoms and signs of suspected intracranial hy-
pertension, such as headaches, nausea, vomiting, and visual 
disturbances. A full clinical and neuroimaging examination, 
including a detailed brain CT, MRI scan and visual exam, was 
performed in each one of them, to exclude other pathologies.
For the purpose of this research study, we used the ICP 
telemetry system (Neurovent® P-tel Raumedic®). The telem-
etry hardware has 3 parts:
 1. an implantable device made consisting of a) the intra-
parenchymal portion: a piezoresistive pressure transducer 
with several electric resistors doped on a flexible mem-
brane, located at the tip of a polyurethane catheter 30mm 
long and 1.67mm thick, in direct contact with the pulsating 
brain tissue and b) the portion remaining under the skin: 
a 31.5mm in diameter and 4.3mm thick round ceramic 
housing a microchip, which converts transducer’s electric 
plateau Lundberg B
FiguRe 2. Lundberg type A (plateau)/Lundberg type B waves.
FiguRe 3. MRI: Aqueduct stenosis.
modifications into ICP values (Figure 5).
 2. a portable device - ICP recording and storage monitor 
(Raumedic® TDT 1) (Figure 6).
 3. a signal transfer antenna (Raumedic® Reader TDT 1) 
from the implanted device to the monitor based on radi-
ofrequency identification technique5,6,8,14-20 (Figure 7).
The implantation of P-tel can be performed either under 
general or local anesthesia. The ICP insertion point is the 
Kocher point: 12 cm from the middle cortical line and 2.5 cm 
from the midline or 2 cm in front of the coronary suture. After 
a 4 cm skin incision over the Kocher point, the telemetric de-
vice is implanted through a burr hole and opening of the dura, 
into the right frontal lobe parenchyma (Figures 8, 9). The left 
frontal lobe (dominant side) could also be used if necessary. 
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FiguRe 4. MRI: Idiopathic Intracranial Hypertension.
FiguRe 6. Raumedic TDT 1. 
FiguRe 7. Raumedic Reader TDT 1.
FiguRe 5. Neuroment P-tel. 
FiguRe 8. Kocher’s point.
The wound is closed with skin sutures instead of surgical staples 
to avoid interferences during telemetric data transmission. 
Surgical removal after 3-6 months requires local anesthesia.
The intracranial device couples with the external antenna 
placed upon the scalp and measures ICP in real time if con-
nected to the monitor. The acquired data can be analyzed and 
interpreted with a specialized software in a personal computer 
and enabling identification of pathologic Lundberg waves. The 
device has the capacity to store continuous ICP recordings 
for 72 hours. 
TELEMETRIC MONITORING OF INTRACRANIAL PRESSURE
43
The choice of the above system was made for the follow-
ing reasons:
 - No calibration needed.
 - It is placed under the skin under aseptic conditions, hav-
ing the advantage of “non-open” trauma and infections’ 
avoidance.
 - It allows for long-term follow-up, without affecting the 
quality of patients’ lives, also reducing significantly their 
hospitalization time.
 - It enables direct recording, storage and data transfer by 
enabling the analysis of these via a computer, using special 
software.
 - It is not compromised by magnetic fields of up to 3 Tesla, 
giving the patient the ability to undergo MRI after surgery, 
if necessary.8,15,16
All six involved patients underwent telemetric ICP moni-
toring and recording for 72 hours, starting immediately after 
implantation in the nursing unit. Three further recordings fol-
lowed at two, four and six months post-implantation at home 
for 48-72 hours each time. The ICP recordings were examined 
during daytime and nighttime, for episodes of raised ICP and 
evaluation of ICP waves’ morphology such as presence of 
pathologic Lundberg B-waves or A-waves.
R e S u l T S
After analysis of the recording data, intracranial hyper-
tension was not confirmed in two patients. In contrast, four 
patients recorded with increased intracranial pressure and 
eventually two of them underwent V-P shunt implantation 
and one L-P shunt implantation. One patient refused further 
neurosurgical intervention. Two of the patients are still under 
medical attendance (Table 1).
The above patients underwent a total of 890 hours of ICP 
recording and monitoring as follows:
 - The 23-year-old female patient (No 1) had normal brain 
MRI scan and with ICP telemetry she recorded negative 
ICP values, up to -18mmHg. A local cerebral oedema 
around the intracranial catheter position was observed in 
a brain CT scan, one month following ICP probe implanta-
tion. Eventually, no further neurosurgical action suggested.
 - The 33-year-old female patient (No 2) experienced severe 
headache in association with progressively deteriorating 
gait instability. The patient had a brain MRI scan which 
showed possible stenosis of the aqueduct. She was initially 
treated with acetazolamide, without any improvement in 
symptoms. ICP Telemetry proved high ICP values. After 
the V-P shunt insertion, the values  initially measured near 
the upper normal limits. Subsequently, during a six-month 
follow-up period, with appropriate regulation of the valve 
mechanism, ICP values measured within normal range. 
At the same time, both headaches and walking instability 
disappeared.
 - Similarly, the 63-year-old male patient (No 3) had a brain 
MRI with possible aqueduct stenosis. ICP telemetry re-
corded elevated ICP values, particularly at night. After 
implantation of a V-P shunt the ICP restored to normal 
values.
 - The 22-year-old female patient (No 4), with the empty 
sella syndrome presented with very high ICP values (> 
28mmHg) throughout the telemetry study. However, she 
refused any further neurosurgical treatment.
 - The 21-year-old male patient (No 5) found with brain 
FiguRe 9. Surgical implantation procedure: Steps: 1. skin preparation, 2. skin incision, 3. burr hole opening.
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Table 1. Patients’ demographic, clinical, radiology & ICP monitoring data
Α/Α sex age 
yrs
ΒΜΙ V.F. MRI/ 
suspected 
diagnosis
ICP...mmHg 
post ICP 
implantation
V-P 
shunt
l-P 
shunt
ICP 
post-op
ICP 2 
months
ICP 4 
months
ICP 6 
months
comment
1 F 23 3 + without 
findings/BIH
<15 - - - <15 <15 <15
2 F 33 2 + Aqueduct 
stenosis/
Occlusive 
Hydrocephalus
>40 + <20 <15 <15 <15
3 M 63 3 - Aqueduct 
stenosis/cclusive 
Hydrocephalus
>30 + <20 <15 <15 <15
4 F 22 4 - Empty  
sella/BIH
>40 - - - >40 - - Refusal
5 M 21 2 - NPH <20 - - - <15 <15 - In study
6 F 58 4 - without 
findings/BIH 
>40 - + <25 <20 - - In study
Body mass index - BMI 1: <18,5: underweight Visual Fields: V.F. + : with deficit
 BMI 2: 18,5-24,9: normal weight   - : without deficit
 BMI 3: 25-29,9: overweight
 BMI 4: >30: obesity
ventricular dilatation in a random brain CT imaging for a 
mild traumatic head injury, without history of any neuro-
logical symptoms or signs. The ICP telemetric recordings 
were within normal limits. He presented with a generalised 
epileptic seizure one week after removal of the ICP bolt 
due to a small intracerebral haemorrhage. He received 
conservative treatment for 3 months.
 - The 58-year-old female patient (No 6) presented with one 
year history of spontaneous rhinorrhea, without known 
trauma mechanism. She had a brain MRI scan, in which 
a CSF leak was detected through the ethmoid bone and 
subsequently she was treated with an endoscopic proce-
dure. The ICP telemetry proved very high ICP values. She 
underwent a L-P shunt insertion and the ICP returned to 
normal values. She remains in study.
It is interesting to mention that all patients with increased 
intracranial pressure, independently of their pathology, 
experienced elevated ICP values during night time sleep, 
particularly between 3:00 am and 6:00 am, with increase of 
ICP >25mmHg (Lundberg B waves) for maximum duration 
of 2 minutes (Figure 10). 
In our series the overall clinical complication rate after 
Neurovent® P-tel Raumedic® implantation was limited. None 
technical problems occurred. One female patient (No 1) 
presented with a radiological finding of a small brain oedema 
around the ICP bolt one month following the implantation, 
without clinical consequences. In addition one male patient 
(No 5) presented with a generalised epileptic seizure one 
week after removal of the ICP bolt. The post-op brain CT 
scan, showed a small 2 cm intraparenchymal clot into the 
right frontal lobe around the bolt position. No surgical action 
required and he was treated with antiepileptics for 3 months, 
without further consequences. 
More patients are scheduled to be included in our study, 
in order ICP telemetry efficacy and complication rate to be 
further clarified.
d i S C u S S i o n 
For more than 50 years techniques enabling wireless ICP 
measurement and monitoring were demanded by several in-
vestigators in the literature.8,16 Monitoring of the ICP under 
non-hospital conditions and the possibility of performing 
long-term measurement without increased risk of infection or 
delivering of imprecise ICP data, were the main anticipated 
advantages.8,16
Eventually, in 2009 the Neurovent® P-tel Raumedic® 
telemetric device was introduced promising reliability on ICP 
recorded values.16 Thereafter, handling of the system proved 
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simple for the doctors / nursing staff as well as for the patients 
during their hospital stay or even at home, while lying, sleep-
ing or walking. Implantation and removal procedure proved 
easy to perform and there is no cable connection between 
the brain and ICP monitor. The system could be remained 
implanted for long periods and not only for 5-10 days as hap-
pens with the conventional ICP recording systems. However, 
a second operation under local anaesthesia to remove the 
probe, is required.
The present study shows the ability of using telemetric ICP 
measurements for long-term evaluation of ICP in patients with 
inconclusive diagnosis of diseases such as benign intracranial 
hypertension (BIH), aqueduct stenosis and normal pressure 
hydrocephalus (NPH). Particularly, in patients with suspected 
BIH, opening pressure at lumbar punctures as well as clinical, 
ophthalmologic and radiologic criteria are not sometimes suf-
ficient to confirm BIH. Similarly, the suspected NPH patients 
could avoid unnecessary shunting since, according to the 
literature, clinical and radiological findings have only limited 
prognostic value. Increased activity of Lundberg B waves, es-
pecially at night, could be associated with NPH, despite their 
disputed predictive value. Moreover, literature shows that in 
shunted patients, imaging studies (CT, MRI), shunt radiog-
raphy series, clinical and ophthalmologic data are not always 
reliable in indicating shunt malfunction (under-drainage or 
over-drainage). Telemetric ICP records could guide to valve 
readjustment for optimization of programmable shunt’s set-
tings, surgical exploration and revision of shunt if necessary 
and direct documentation of the post-adjustment or post-
operative ICP normalization. On the other hand, Lundberg 
A waves in patients with suspected aqueduct stenosis must 
always be considered as abnormal findings indicating further 
neurosurgical action. 
Moreover, as we mentioned in Results section, all patients 
with increased intracranial pressure, independently of their 
pathology, experienced elevated ICP values during night time 
sleep, particularly between 3:00 am and 6:00 am, with increase 
of ICP >25mmHg (Lundberg B waves) for a maximum du-
ration of 2 minutes. This effect was observed even after the 
implantation of a shunt mechanism, although with lower ICP 
values. Whether the sleeping state of REM or any other sleep-
ing state affects the waveform of ICP (B-waves), is a question 
that needs to be further clarified.8-20
In larger series of patients the overall clinical complication 
rate after P-tel implantation was 7.3% including temporary 
hemiparesis, small intracerebral haemorrhage, new-onset 
seizures and infections (brain abscesses or superficial wound 
infections). Moreover, the technical problems due to defects 
or damages of the device occurred in a rate of less than 3%. 
These incidences were comparable with the complication rate 
FiguRe 10. Β-waves (P1<P2).
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after insertion of conventional ICP recording systems. In our 
small series of 6 patients, one patient presented with a local 
cerebral oedema around the intracranial catheter position in 
a brain CT scan, without neurological symptoms, one month 
following ICP probe implantation and a second patient pre-
sented with an epileptic seizure one week post removal of the 
ICP bolt due to a very small intraparenchymal hematoma. Both 
patients were treated conservatively without further problems. 
It’s interesting to mention that the perifocal small oedematous 
reactions surrounding inserted telemetric catheters could be 
observed up to 46.9 % in literature. Presumably long term fixed 
implants may induce some damage to the surrounding tissue 
resulting from pulsation of the brain. Additionally, the initial 
local tissue trauma during P-tel insertion may contribute to 
the oedema development. This oedema has the tendency of 
complete resolution over time.8,16
It is obvious that even using the P-tel telemetric device, 
limitations still exist. The Reader TDT antenna must be po-
sitioned and fixed over the implant on the head skin for con-
tinuous ICP measurements and thus the patients are limited 
with regard to their out-hospital activities. It would be more 
desirable if the antenna receives data from the implanted 
probe, without direct patient contact. Moreover, further 
improvements in system hardware and software need to be 
considered. Finally, the disadvantage of a second operation 
to remove the probe, remains.18-20
Lastly, we need to clarify that insertion of a telemetric 
device should not be generally recommended for all patients 
with BIH, NPH, shunt or aqueduct stenosis. Quite often clini-
cal and radiologic signs are sufficient to confirm diagnosis and 
consequently it is proposed that the decision whether ICP 
telemetric measurement should be performed needs to be 
considered on a case by case basis.18-20
C o n C l u S i o n S
ICP telemetry, despite its limitations, allows long-term ICP 
recordings in patients with suspected intracranial hypertension 
and clinical and imaging inconclusive data, even outside the 
nursing unit. 
ICP telemetry could be safely implanted via a rather simple 
procedure and allows significant reduction of hospitaliza-
tion time and overall cost. Patients with normal recordings 
avoid unnecessary shunt implantations, making them “shunt-
dependents” for the rest of their lives, under the shadow of 
long-term shunt-related complications. In addition shunted 
patients could be benefited by telemetric confirmation of CSF 
over- or under-drainage.
In selected patients telemetric ICP recording has suf-
ficient potential to become established in clinical routine, 
in order to confirm diagnoses and guide to the appropriate 
treatments.
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